Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review

Comprehending the pathogenesis of schizophrenia represents a challenge for global mental health. To date, although it is evident that alterations in dopaminergic, serotonergic, and glutamatergic neurotransmission underlie the clinical expressiveness of the disease, neuronal disconnections represent...

Descripción completa

Detalles Bibliográficos
Autores principales: Messina, Antonino, Concerto, Carmen, Rodolico, Alessandro, Petralia, Antonino, Caraci, Filippo, Signorelli, Maria Salvina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296023/
https://www.ncbi.nlm.nih.gov/pubmed/37371435
http://dx.doi.org/10.3390/brainsci13060957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296023/
https://www.ncbi.nlm.nih.gov/pubmed/37371435
http://dx.doi.org/10.3390/brainsci13060957

Ejemplares similares